Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 20.2B | 21.5B | 19.9B | 22.2B |
Cost of revenue | 19.0B | 20.1B | 18.6B | 20.9B |
Gross profit | 1.2B | 1.4B | 1.4B | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 932M | 943M | 905M | 907M |
Other operating expenses | — | — | — | — |
Operating income | 248M | 415M | 460M | 489M |
Non operating interest income | ||||
Income | 138M | 162M | 137M | 140M |
Expense | 158M | 179M | 174M | 187M |
Other income expense | 125M | 269M | -315M | 154M |
Pretax income | 353M | 667M | 108M | 596M |
Tax provision | 61M | 106M | 90M | 115M |
Net income | 292M | 561M | 18M | 481M |
Basic EPS | 0.6 | 1.2 | 0.0 | 1.0 |
Diluted EPS | 0.6 | 1.2 | 0.0 | 1.0 |
Basic average shares | 483M | 478M | 482M | 495.9M |
Diluted average shares | 483M | 484M | 483M | 495.9M |
EBITDA | 828M | 1.1B | 1.1B | 1.1B |
Net income from continuing op. | 292M | 561M | 18M | 481M |
Minority interests | 3M | 6M | 0 | 5M |
Preferred stock dividends | — | — | — | — |